Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
BeOne Medicines
Janux Therapeutics
Regeneron Pharmaceuticals
Genentech, Inc.
Vir Biotechnology, Inc.
Eli Lilly and Company
Janssen Research & Development, LLC
MOMA Therapeutics
Eli Lilly and Company
C Ray Therapeutics
Aragon Pharmaceuticals, Inc.
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Eli Lilly and Company
Nammi Therapeutics Inc
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Acerand Therapeutics Limited
Exscientia AI Limited
ARTBIO Inc.
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Zumutor Biologics Inc.
Novartis
Agenus Inc.
Amgen
Amgen
K36 Therapeutics, Inc.
Orano Med LLC
TechnoGenesys, Inc.
Merck Sharp & Dohme LLC
AstraZeneca
Atavistik Bio, Inc
Gan & Lee Pharmaceuticals.
Alterome Therapeutics, Inc.
Merck Sharp & Dohme LLC
Eli Lilly and Company
ViroMissile, Inc.
AstraZeneca
Regeneron Pharmaceuticals
SURGE Therapeutics
Tizona Therapeutics, Inc
Astellas Pharma Inc
Janssen Research & Development, LLC
Clasp Therapeutics, Inc.
Amgen